MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1
出版年份 2013 全文链接
标题
MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1
作者
关键词
miR-497, Neuroblastoma, <em class=EmphasisTypeItalic >WEE1</em>, Tumor suppressor, Cisplatin
出版物
Molecular Cancer
Volume 12, Issue 1, Pages 23
出版商
Springer Nature
发表日期
2013-03-26
DOI
10.1186/1476-4598-12-23
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome
- (2012) J Ryan et al. BRITISH JOURNAL OF CANCER
- MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway
- (2012) Jennifer Lynch et al. CARCINOGENESIS
- Inhibition of Neuroblastoma Tumor Growth by Targeted Delivery of MicroRNA-34a Using Anti-Disialoganglioside GD2 Coated Nanoparticles
- (2012) Amanda Tivnan et al. PLoS One
- High Expression of Wee1 Is Associated with Poor Disease-Free Survival in Malignant Melanoma: Potential for Targeted Therapy
- (2012) Gry Irene Magnussen et al. PLoS One
- MicroRNA-542-5p as a novel tumor suppressor in neuroblastoma
- (2011) Isabella Bray et al. CANCER LETTERS
- MicroRNAs 10a and 10b are potent inducers of neuroblastoma cell differentiation through targeting of nuclear receptor corepressor 2
- (2011) N H Foley et al. CELL DEATH AND DIFFERENTIATION
- Analysis of MiR-195 and MiR-497 Expression, Regulation and Role in Breast Cancer
- (2011) D. Li et al. CLINICAL CANCER RESEARCH
- WEE1 Kinase Targeting Combined with DNA-Damaging Cancer Therapy Catalyzes Mitotic Catastrophe
- (2011) P. C. De Witt Hamer et al. CLINICAL CANCER RESEARCH
- Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice
- (2011) Elisa Giovannetti et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- miR-497 and miR-302b Regulate Ethanol-induced Neuronal Cell Death through BCL2 Protein and Cyclin D2
- (2011) Sanjay Yadav et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2
- (2011) Wei Zhu et al. MEDICAL ONCOLOGY
- In Silico Analysis of Kinase Expression Identifies WEE1 as a Gatekeeper against Mitotic Catastrophe in Glioblastoma
- (2010) Shahryar E. Mir et al. CANCER CELL
- microRNAs regulate human embryonic stem cell division
- (2010) Junlin Qi et al. CELL CYCLE
- Chromosomal and MicroRNA Expression Patterns Reveal Biologically Distinct Subgroups of 11q- Neuroblastoma
- (2010) P. G. Buckley et al. CLINICAL CANCER RESEARCH
- Accurate prediction of neuroblastoma outcome based on miRNA expression profiles
- (2010) Johannes H. Schulte et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2
- (2010) Niamh H Foley et al. Molecular Cancer
- Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents
- (2009) H. Hirai et al. MOLECULAR CANCER THERAPEUTICS
- MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors
- (2009) P Mestdagh et al. ONCOGENE
- Integrated Functional, Gene Expression and Genomic Analysis for the Identification of Cancer Targets
- (2009) Elizabeth Iorns et al. PLoS One
- Widespread Dysregulation of MiRNAs by MYCN Amplification and Chromosomal Imbalances in Neuroblastoma: Association of miRNA Expression with Survival
- (2009) Isabella Bray et al. PLoS One
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
- (2008) Susan L. Cohn et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started